Logo Home About Us Products Contact Us

PRESS RELEASE - May 30 , 2008

CAVIT SCIENCES, INC. ANNOUNCES ASSET PURCHASE AGREEMENT

Contact: Colm King
561-544 6988
info@cavitsciences.com

www.CavitSciences.com

Boca Raton, FL, May 30, 2008—Cavit Sciences, Inc. (“Cavit”) (OTCBB: CVIT) announced today that it completed an Asset Purchase Agreement with Alternecare Health Products, Inc. (“Alternecare™”) on May 28, 2008.

Alternecare™ is an innovator and leader in combining rapid home diagnostics with therapeutic nutraceutical based solutions, has penetrated the retail market in the US and has initiated the process to establish itself in the e-commerce marketplace. Cavit acquired Alternecare™’s inventory, customer lists, existing relationships, trademark and website.

Most importantly, Cavit acquired the consulting services of Ismael Gonzalez, Alternecare™’s President. Ismael has over 15 years of management experience in the natural products industry. He has held business development roles with top companies ranging from manufacturing to distribution. His business development expertise will be instrumental in Cavit’s future.

Alternecare™’s product line joins Cavit’s other two supplement lines, MD Solution™ and AMERICARE HEALTH PRODUCTS™. Its brand awareness and presence in the retail market will assist the launch of Cavit’s additional products and lines.

An overview of Alternecare™’s products is available on its website: www.alternecare.com

For additional information about this udpate, please visit www.CavitSciences.com.

About Cavit Sciences - Cavit Sciences, Inc. (“Cavit”) is a biotechnology company that has three developed supplement lines with products that enhance, improve, maintain and support the body by beneficially affecting various conditions and is engaged in developing treatments and prevention for cancer, viral infections, opportunistic infections, related diseases and the immune system. New product information and updates will continue to be added to Cavit’s website.

- END -

© 2008 Cavit Sciences


[Print This Page]